Astrazeneca Pharmaceuticals Lp v. Apotex Corp.

NOTE: This order is nonprecedential United States Court of AppeaIs for the Federal Circuit ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, IPR PHARMACEUTICALS INC., AND THE BRIGHAM AND WOMEN’S HOSPITAL, INC., Plaintiffs~Appello:nts, 4 v. APOTEX CORP., Defendan,t-Appellee, and AUROBINDO PHARMA LIMITED, Defendant-Appellee, and COBALT PHARMACEUTICA.LS INC. AND COBALT LABORATORIES INC., Defen,dan,ts-Appellees, § and GLENM.ARK GENERICS INC. USA, Defenclan,t-Appellee, and MYLAN PHARMACEUTICALS INC., Defen.dant-Appellee, and PAR PHARMACEUTICALS, INC., ASTRAZENECA PI-lARMA V. APOTEX CORP 2 Defendcmt-Appellee, and SUN PHARMACEUTICAL INDUSTRIES, LTD., Defendcmt-Appellee, and TEVA PHARMACEUTICALS USA, INC., Defen,dan,t-Appellee, and 4 TORRENT PHARMA INC. AND TORRENT PHARMACEUTICALS LTD., Defendcmts. 2011-1182, -1183, -1}.84, -1185, -1186, -1187, -1188, -1189, -1190 Appeals from the United States District Court for the District of De1aWare in case nos. 10-CV-0338, 10-CV-0339, 10-CV-034O, 10-CV-0341, 10-CV-0342, 10-CV-O343, 10- CV-O345, 10-CV-0346, and 10-CV-0584, Judge Robert B. Kug1er. ON MOTION ORDER Upon consideration of the motion to withdraw Dutch Chung as principal counsel for Par Phar1naceutica1s, Inc., IT IS ()RDERED THAT: (1) The motion is granted 3 ASTR.AZENECA PHA.RMA V. A.POTEX CORP (2) New principal counsel for Par Pharmaceutica1s, Inc. must promptly enter a new entry of appearance FoR THE CoURT HAY 1 0 2011 /S/ Jan H0rba1y Date J an Horbaly CC. S Mary W. Bourke, Esq. Francis J. Murphy, Jr., Esq. R0bert B. Breisb1att, ESq. Shane A. Brunner, Esq. Steven A. Maddox, Esq. H. Keeto Sabharwa1, Esq. Wi1liam A. Rakoczy, Esq. Dutch Chung, Esq. Nic0le W. Stafford, Esq. Ja1nes F. Hurst, Esq. Jeff`ry M. Nicho1s, Esq. Clerk F u.s. count i)'FEi=)PEALs FOR THE FEoERAL c1RcuzT l“|AY 10 2011 gin mem citrus